Market open
OptimizeRx/$OPRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OptimizeRx
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Ticker
$OPRX
Sector
Trading on
Industry
Health Care Technology
Headquarters
Employees
129
Website
OptimizeRx Metrics
BasicAdvanced
$160M
-
-$1.10
1.31
-
Price and volume
Market cap
$160M
Beta
1.31
52-week high
$14.13
52-week low
$3.78
Average daily volume
314K
Financial strength
Current ratio
2.893
Quick ratio
2.766
Long term debt to equity
26.518
Total debt to equity
28.371
Interest coverage (TTM)
-1.01%
Management effectiveness
Return on assets (TTM)
-2.19%
Return on equity (TTM)
-16.51%
Valuation
Price to revenue (TTM)
1.72
Price to book
1.37
Price to tangible book (TTM)
260.7
Price to free cash flow (TTM)
35.688
Growth
Revenue change (TTM)
28.81%
Earnings per share change (TTM)
6.80%
3-year revenue growth (CAGR)
14.55%
3-year earnings per share growth (CAGR)
280.30%
What the Analysts think about OptimizeRx
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for OptimizeRx stock.
OptimizeRx Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
OptimizeRx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
OptimizeRx News
AllArticlesVideos
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
GlobeNewsWire·5 days ago
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
GlobeNewsWire·1 week ago
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million
Benzinga·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for OptimizeRx stock?
OptimizeRx (OPRX) has a market cap of $160M as of April 28, 2025.
What is the P/E ratio for OptimizeRx stock?
The price to earnings (P/E) ratio for OptimizeRx (OPRX) stock is 0 as of April 28, 2025.
Does OptimizeRx stock pay dividends?
No, OptimizeRx (OPRX) stock does not pay dividends to its shareholders as of April 28, 2025.
When is the next OptimizeRx dividend payment date?
OptimizeRx (OPRX) stock does not pay dividends to its shareholders.
What is the beta indicator for OptimizeRx?
OptimizeRx (OPRX) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.